ArriVent BioPharma (AVBP) Stock Chart & Stock Price History $23.28 -1.22 (-4.98%) Closing price 06/11/2025 04:00 PM EasternExtended Trading$23.30 +0.02 (+0.09%) As of 06/11/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ArriVent BioPharma Stock Price Performance The ArriVent BioPharma (AVBP) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 24.76%, with a year-to-date return of -12.61%. In the past month, the stock has increased 16.46%, reflecting recent market activity. As of the latest close, ArriVent BioPharma traded at $23.28 with a market cap of $796.48 million and volume of 179,002 shares. Receive AVBP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ArriVent BioPharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-1.02%1 Month Performance+16.46%3 Month Performance+3.70%Year-To-Date Performance-12.61%1 Year Performance+24.76% AVBP Stock Chart for Thursday, June, 12, 2025 AVBP Chart by TradingView ArriVent BioPharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/11/2025$24.50$23.28-4.98%$25.07$23.20179,002 shs$796.48 million06/10/2025$23.60$24.50+3.81%$24.75$23.76322,545 shs$838.22 million06/09/2025$23.52$23.60+0.34%$24.05$23.20199,839 shs$807.43 million06/06/2025$23.47$23.52+0.21%$23.91$23.19219,200 shs$804.69 million06/05/2025$22.72$23.47+3.30%$24.05$22.50529,702 shs$802.98 million06/04/2025$23.12$22.72-1.73%$23.77$22.66386,063 shs$777.32 million06/03/2025$22.00$23.12+5.09%$23.55$21.93569,421 shs$791.01 million06/02/2025$21.20$22.00+3.77%$22.42$21.01588,332 shs$752.69 million05/30/2025$21.00$21.20+0.95%$21.61$20.18310,649 shs$725.32 million05/29/2025$20.04$21.00+4.79%$21.44$19.98577,312 shs$718.47 million Get the Latest News and Ratings for AVBP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ArriVent BioPharma and its competitors with MarketBeat's FREE daily newsletter. 05/28/2025$20.63$20.04-2.86%$20.77$19.80302,038 shs$685.63 million05/27/2025$20.40$20.63+1.13%$20.86$20.07261,226 shs$705.81 million05/26/2025$20.40$20.40$20.70$19.62360,630 shs$697.95 million05/23/2025$20.63$20.40-1.11%$20.70$19.62360,630 shs$697.95 million05/22/2025$20.47$20.63+0.78%$21.16$19.74336,382 shs$705.81 million05/21/2025$20.86$20.47-1.87%$21.07$19.99174,496 shs$700.34 million05/20/2025$19.35$20.86+7.80%$21.05$19.09470,590 shs$713.68 million05/19/2025$19.36$19.35-0.05%$19.52$18.70165,130 shs$662.02 million05/16/2025$19.24$19.36+0.62%$19.55$18.97136,991 shs$662.36 million05/15/2025$18.75$19.24+2.61%$19.33$18.51167,072 shs$655.03 million05/14/2025$19.10$18.75-1.83%$19.57$18.74166,795 shs$638.34 million05/13/2025$19.99$19.10-4.45%$19.91$19.03151,213 shs$650.26 million05/12/2025$19.97$19.99+0.10%$21.21$18.86241,124 shs$680.56 million Related Companies MoonLake Immunotherapeutics Stock Chart Catalyst Pharmaceuticals Stock Chart Metsera Stock Chart Crinetics Pharmaceuticals Stock Chart Viking Therapeutics Stock Chart MorphoSys Stock Chart Scholar Rock Stock Chart Immunovant Stock Chart HUTCHMED Stock Chart Apellis Pharmaceuticals Stock Chart Receive AVBP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ArriVent BioPharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AVBP) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump Makes Major Crypto AnnouncementPay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift ...Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredMarch 16th -- America’s most important day?50-Year Legend: Here's The Day Stocks Likely Crash Legendary quant analyst Marc Chaikin says in 50 years on...Chaikin Analytics | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ArriVent BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ArriVent BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AVBP Stock Free AVBP Stock Alerts